| Literature DB >> 34514166 |
Michele Del Zingaro1, Giovanni Cochetti1, Giuseppe Maiolino2, Davide Stivalini1, Giulia Manfredini1, Angelica Tancredi1, Graziano Felici1, Sara Ciarletti1, Gianluca Gaudio1, Jacopo Adolfo Rossi de Vermandois1, Ettore Mearini1.
Abstract
INTRODUCTION: Several studies have shown the consequences of COVID-19 pandemic on perceived stress of different populations, but none of them analyzed urological patients who underwent elective surgery.Entities:
Keywords: COVID-1; PSS-4; stress levels; urologic patients; urologic surgery
Year: 2021 PMID: 34514166 PMCID: PMC8389503 DOI: 10.1515/med-2021-0289
Source DB: PubMed Journal: Open Med (Wars)
Demographic data and univariate analysis of mean values of PSS-4 at hospital admission
| Variables | Patients | PSS-4 at admission (mean ± SD) | ||
|---|---|---|---|---|
| Population study | 200 (100) | 6.04 ± 3.38 | ||
| Age (years) | 20–40 | 12 (6) | 4.17 ± 1.75 | <0.01* |
| 41–60 | 30 (15) | 6.43 ± 3.09 | ||
| 61–70 | 68 (34) | 5.22 ± 3.11 | ||
| 71–85 | 90 (45) | 6.78 ± 3.63 | ||
| Gender | Men | 186 (93) | 5.78 ± 3.16 | <0.01* |
| Women | 14 (7) | 9.50 ± 4.38 | ||
| Education level | Primary school | 26 (13) | 8.77 ± 3.04 | <0.01* |
| Secondary school | 64 (32) | 4.94 ± 3.52 | ||
| High school | 70 (35) | 5.80 ± 2.76 | ||
| Academic degree | 40 (20) | 6.45 ± 3.44 | ||
| Marital status | Single | 8 (4) | 2.00 ± 2.14 | <0.01* |
| With a partner | 178 (89) | 5.96 ± 3.07 | ||
| Widowhood | 14 (7) | 9.43 ± 4.73 | ||
| Household type | Partner | 110 (55) | 5.81 ± 3.04 | <0.01* |
| Partner plus children | 64 (32) | 5.95 ± 3.03 | ||
| Other family members | 4 (2) | 3.00 ± 2.00 | ||
| Alone | 22 (11) | 8.00 ± 5.14 | ||
| Smoking status | Never or former smoker | 164 (82) | 6.39 ± 3.46 | <0.01* |
| Current smoker | 36 (18) | 4.44 ± 2.49 | ||
| Alcohol use | Not | 130 (65) | 6.29 ± 3.56 | 0.15 |
| Yes | 70 (35) | 5.57 ± 2.99 | ||
PSS-4: 4-item perceived stress scale; *p < 0.05 with t-unparied test or ANOVA.
Medical history data and univariate analysis of mean values of PSS-4 at hospital admission
| Variables | Patients | PSS-4 at admission (mean ± SD) | ||
|---|---|---|---|---|
| Population study | 200 (100) | 6.04 ± 3.38 | ||
| Age-adjusted Charlson comorbidity index | ≤5 | 114 (57) | 6.00 ± 3.35 | 0.85 |
| >5 | 86 (43) | 6.09 ± 3.45 | ||
| BZDs use | Not | 174 (87) | 5.70 ± 3.22 | <0.01* |
| Yes | 26 (13) | 8.35 ± 3.59 | ||
| Antidepressants use | Not | 196 (98) | 5.93 ± 3.31 | <0.01* |
| Yes | 4 (2) | 11.50 ± 2.38 | ||
| Disease | Not oncological | 32 (16) | 4.75 ± 2.44 | 0.02* |
| Oncological | 168 (84) | 6.29 ± 3.48 | ||
| Organ-involved | Bladder | 82 (41) | 6.22 ± 3.25 | <0.01* |
| Prostate | 72 (36) | 5.85 ± 2.84 | ||
| Kidney | 26 (13) | 8.23 ± 4.26 | ||
| Ureter or pelvicalyceal systems | 16 (8) | 3.06 ± 2.35 | ||
| Testis | 4 (2) | 3.50 ± 2.38 | ||
| Months from diagnosis | ≤5 | 86 | 5.66 ± 3.38 | 1.17 |
| >5 | 114 | 6.32 ± 3.37 | ||
| Number of previous surgical procedure | ≤5 | 138 | 6.39 ± 3.33 | 0.03* |
| >5 | 62 | 5.26 ± 3.40 | ||
| History of radiotherapy | Not | 182 | 6.03 ± 3.48 | 0.89 |
| Yes | 18 | 6.11 ± 2.25 | ||
| History of chemotherapy | Not | 192 | 6.08 ± 3.40 | 0.38 |
| Yes | 8 | 5.00 ± 2.83 | ||
| History of bladder instillations | Not | 132 | 6.42 ± 3.41 | 0.03* |
| Yes | 68 | 5.31 ± 3.24 | ||
| Type of procedure | Open surgery | 12 | 4.67 ± 3.37 | 0.00* |
| Laparoscopic-assisted | 4 | 4.75 ± 1.50 | ||
| Endoscopic | 126 | 5.56 ± 3.12 | ||
| Robot-assisted | 58 | 7.45 ± 3.65 | ||
PSS-4: 4-item perceived stress scale; BZDs: benzodiazepines; *p < 0.05 with t-unparied test or ANOVA.
Survey on COVID-19 and univariate analysis of mean values of PSS-4 at hospital admission
| Patients | PSS-4 at admission (mean ± SD) | |||
|---|---|---|---|---|
| Previous positive test for SARS-CoV-2 | Not | 200 | 6.04 ± 3.38 | — |
| Yes | 0 | 0 ± 0 | ||
| Close contact with people with positive test for SARS-CoV-2 | Not | 192 | 6.08 ± 3.42 | 0.38 |
| Yes | 8 | 5.00 ± 2.14 | ||
| Fear of intrahospital infection of SARS-CoV-2 (range 0–10) | ≤5 | 154 | 5.12 ± 2.82 | 0.000* |
| >5 | 46 | 9.13 ± 3.30 | ||
| Trust in PPE (range 0–10) | ≤5 | 76 | 6.11 ± 3.66 | 0.83 |
| >5 | 124 | 6.00 ± 3.21 | ||
PPE: personal protective equipment. *p < 0.05 with t-unparied test or ANOVA.
Univariate and multivariate logistic regression analysis of clinical factors in predicting PSS-4 ≥7 (n = 87/200–43.5%)
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Age classes | ||||||
| 20–70 | Reference | |||||
| 71–85 | 2.26 | 1.28–4.01 |
| 1.79 | 0.89–3.57 | 0.09 |
| Gender | ||||||
| Male | Reference | |||||
| Female | 5.30 | 1.43–19.66 |
| 6.42 | 1.08–39.1 |
|
| Level of education | ||||||
| Academic degree | Reference | |||||
| Primary school | 1.89 | 0.68–5.22 | 0.221 | — | — | — |
| Secondary school | 0.49 | 0.22–1.09 | 0.083 | — | — | — |
| High school | 0.71 | 0.32–1.54 | 0.385 | — | — | — |
| Marital status | ||||||
| Widowhood | Reference | |||||
| Single | 0.00 | — | 0.99 | — | — | — |
| With a partner | 0.30 | 0.092–1.00 | 0.052 | — | — | — |
| Household type | ||||||
| Partner | Reference | |||||
| Partner plus children | 0.92 | 0.49–1.71 | 0.79 | — | — | — |
| Other family members | 0.00 | — | 0.99 | — | — | — |
| Alone | 2.34 | 0.91–6.05 | 0.78 | — | — | — |
| Smoking status | ||||||
| Never or former smoker | Reference | |||||
| Current smoker | 0.31 | 0.13–0.71 |
| 0.27 | 0.10–0.72 |
|
| BZD use | ||||||
| No | Reference | |||||
| Yes | 2.32 | 0.99–5.41 | 0.051 | — | — | — |
| Antidepressants use | ||||||
| No | Reference | |||||
| Yes | 0.00 | — | 0.99 | — | — | — |
| Number of previous surgical procedure | ||||||
| ≤5 | Reference | |||||
| >5 | 1.33 | 0.72–2.45 | 0.36 | — | — | — |
| Disease | ||||||
| Not oncological | Reference | |||||
| Oncological | 2.66 | 1.13–6.26 |
| 2.87 | 1.07–7.68 |
|
| Organ-involved | ||||||
| Testis | Reference | |||||
| Bladder | 2.85 | 0.28–28.61 | 0.37 | — | — | — |
| Prostate | 2.02 | 0.20–20.41 | 0.55 | — | — | — |
| Kidney | 4.80 | 043–52.76 | 0.20 | — | — | — |
| Ureter or pelvicalyceal system | 0.20 | 0.01–4.17 | 0.29 | — | — | — |
| History of bladder instillation | ||||||
| Not | Reference | |||||
| Yes | 2.02 | 1.10–3.74 |
| 0.26 | 0.12–0.56 |
|
| Type of procedure | ||||||
| Open surgery | Reference | |||||
| Laparoscopic-assisted | 0.33 | 0.27–4.18 | 0.39 | — | — | — |
| Endoscopic | 0.61 | 0.18–2.01 | 0.42 | — | — | — |
| Robot-assisted | 1.23 | 0.35–4.27 | 0.74 | — | — | — |
| Fear of intrahospital transmission of SARS-CoV-2 infection (1–10) | ||||||
| ≤5 | Reference | |||||
| >5 | 7.27 | 3.34–15.8 |
| 4.75 | 2.06–10.9 |
|
OR: odds radio; CI: confidence interval. Bold indicates that p < 0.05 on univariate and multivariate analysis.